News

Rest assured, we are monitoring and successfully mitigating potential challenges due to ongoing supply chain disruptions to deliver material consistently to our customers. Learn more.

Promega's Cookie Policy

We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we won’t set them unless you accept them. To find out more about cookies and how to manage cookies, read our Cookie Policy.

Citations Search

Sort By:

SLAS Technol. 24, 28–40. Mutation Profiles in Glioblastoma 3D Oncospheres Modulate Drug Efficacy. 2019

Wilson K.M., Mathews-Griner L.A., Williamson T., Guha R., Chen L., Shinn P., McKnight C., Michael S., Klumpp-Thomas C., Binder Z.A., Ferrer M., Gallia G.L., Thomas C.J., Riggins G.J.

Notes: Researchers generated novel glioblastoma 3D cell models to better predict drug efficacy in patients. Two cell lines were used for high-throughput screening, where cell viability and apoptosis assays were used. (5224)

Expand Full Notes »

Cell Death Dis. 7, e2492. Large-scale pharmacological profiling of 3D tumor models of cancer cells 2016

Mathews Griner L.A., Zhang X., Guha R., McKnight C., Goldlust I.S., Lal-Nag M., Wilson K., Michael S., Titus S., Shinn P., Thomas C.J., Ferrer M.

Notes: In this study, researchers used high-throughput compatible 384-well and 1536-well assay plate formats with spheroids of various cell types. Viability and apoptosis of monolayer and 3D tumor models was assessed. (5223)

Expand Full Notes »